ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Systemic sclerosis | 10.04.07.006; 07.11.02.008; 24.03.03.041; 23.03.02.021; 15.06.01.019 | 0.000139% | | Not Available |
Cardiomyopathy acute | 02.04.01.008 | 0.000139% | | Not Available |
Tumour marker increased | 13.22.01.017 | 0.001332% | | Not Available |
Cytomegalovirus enterocolitis | 11.05.01.012; 07.19.01.020 | 0.000417% | | Not Available |
Short-bowel syndrome | 12.02.03.024; 07.17.01.010 | 0.000799% | | Not Available |
Metastases to meninges | 17.02.10.012; 16.22.02.003 | 0.000278% | | Not Available |
Lip erosion | 07.05.01.016 | 0.000533% | | Not Available |
Dihydropyrimidine dehydrogenase deficiency | 14.09.02.001; 03.08.07.001 | 0.001181% | | Not Available |
Cytomegalovirus gastrointestinal infection | 11.05.01.014; 07.19.02.016 | 0.000533% | | Not Available |
Small intestine carcinoma | 16.13.13.002; 07.21.01.016 | 0.000139% | | Not Available |
Clostridium difficile infection | 11.02.02.009 | - | - | Not Available |
Peripheral paralysis | 17.01.04.020 | 0.000533% | | Not Available |
Rectal cancer metastatic | 16.13.01.007; 07.21.05.003 | 0.000208% | | Not Available |
Oesophageal cancer metastatic | 16.13.06.003; 07.21.06.003 | 0.000208% | | Not Available |
Breast cancer metastatic | 21.05.01.016; 16.10.01.008 | 0.001668% | | Not Available |
Colon cancer metastatic | 16.13.01.012; 07.21.01.010 | 0.001181% | | Not Available |
Biliary sepsis | 11.01.18.005; 09.02.01.005 | 0.000799% | | Not Available |
Subacute cutaneous lupus erythematosus | 23.03.02.020; 15.06.02.012; 10.04.03.012 | 0.001865% | | Not Available |
Troponin T increased | 13.04.01.015 | 0.000533% | | |
General physical condition abnormal | 13.15.01.040 | 0.001332% | | Not Available |
Female genital tract fistula | 23.07.04.015; 21.10.05.009; 20.08.01.007; 07.11.05.004 | 0.000208% | | Not Available |
Malignant peritoneal neoplasm | 16.13.04.005; 07.21.03.005 | 0.000139% | | Not Available |
Neutrophil count abnormal | 13.01.06.018 | 0.001865% | | Not Available |
Culture positive | 13.08.02.003 | 0.000799% | | Not Available |
Purulence | 11.01.08.060 | 0.000533% | | Not Available |
Gallbladder enlargement | 09.03.02.005 | 0.000799% | | Not Available |
Mycotic endophthalmitis | 11.03.05.025; 06.04.05.029 | 0.000533% | | Not Available |
Metastatic squamous cell carcinoma | 16.16.01.010 | 0.000139% | | Not Available |
Mucosal exfoliation | 08.01.06.021 | 0.000139% | | Not Available |
Tumour perforation | 16.32.03.031 | 0.000533% | | Not Available |